The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation

Published:2018-07-20 Issue:5 Volume:20 Page:e12961
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Webb Brandon J.¹^ORCID,Harrington Rachel²,Schwartz Jason²,Kammerer Jennifer²,Spalding James²,Lee Edward²,Dodds Bart³,Kaufusi Stephanie³,Goodman Bruce E.³,Firth Sean D.³,Martin Greta³,Sorensen Jeffrey⁴,Hoda Daanish⁵

Affiliation:

1. Division of Infectious Disease; Intermountain Healthcare; Salt Lake City Utah

2. Astellas Pharma Global Development, Inc.; Northbrook Illinois

3. Innovations and Business Development; Intermountain Healthcare; Salt Lake City Utah

4. Statistical Data Center; Office of Research; Intermountain Healthcare; Salt Lake City Utah

5. Intermountain Blood and Marrow Transplant/Acute Leukemia Program; Salt Lake City Utah

Funder

Astellas Pharma Global Development

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12961/fullpdf

Reference48 articles.

1. CMV in hematopoietic stem cell transplantation;Camara;Med J Hematol Infect Dis,2016

2. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia;Green;Blood,2013

3. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality;Liu;Clin Microbiol Infect,2015

4. Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to Day 100 after transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group;Takenaka;Biol Blood Marrow Transplant,2015

5. Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center study;Marchesi;World J Transplant,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral activity of immunosuppressors alone and in combination against human adenovirus and cytomegalovirus;International Journal of Antimicrobial Agents;2024-05

2. Unraveling the potential of 3D bioprinted immunomodulatory materials for regulating macrophage polarization: State-of-the-art in bone and associated tissue regeneration;Bioactive Materials;2023-10

3. Epidemiology, treatment patterns, and disease burden of cytomegalovirus in hematopoietic cell transplant recipients in selected countries outside of Europe and North America: A systematic review;Transplant Infectious Disease;2023-06-08

4. Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high‐risk cytomegalovirus serostatus kidney transplant recipients;Transplant Infectious Disease;2022-11-14

5. Clinical and healthcare burden of disease associated with cytomegalovirus in allogeneic hematopoietic stem cell transplantation – A retrospective single‐center study;Transplant Infectious Disease;2022-09-27